Risk factors for the development of bronchopulmonary dysplasia: a case-control study
Main Article Content
Abstract
DOI: 10.1016/j.rcpe.2016.03.001
Introduction
The development of ventilator support is one of the main factors contributing to the survival of premature infants. However, this has led to lung injury and an increase in the incidence of bronchopulmonary dysplasia.
Methodology
In order to determine risk factors for the development of bronchopulmonary dysplasia in preterm infants, a cases and controls study was designed that included 36 infants with bronchopulmonary dysplasia and compared with 108 controls. A logistic regression model was created to evaluate the effect on the risk of bronchopulmonary dysplasia.
Results
In univariate analysis, the factors associated with bronchopulmonary dysplasia were: FiO2>35% for more than 3 days, hyaline membrane disease, early sepsis, pneumothorax/pulmonary interstitial emphysema, patent ductus arteriosus, 4 or more red blood cell transfusions, and pregnancy induced hypertension. The predictors for the development of bronchopulmonary dysplasia in preterm infants less than 34 weeks were identified using binary logistic regression analysis. These were found to be: pneumothorax or pulmonary interstitial emphysema (odds ratio, OR=1.7; 95% CI; 1.3-9.1; p=.039), and 4 or more red blood cell transfusions (OR=2.1; 95% CI; 1.6-8.1; p=.025). Mortality was higher in the group with bronchopulmonary dysplasia (41.7% vs. 22.2%, p=.023).
Conclusion
Pneumothorax or pulmonary interstitial emphysema, and 4 or more red blood cell transfusions are reliable tools to predict development of bronchopulmonary dysplasia in preterm infants less than 34 weeks. Early diagnosis, corrected air leak syndrome, optimising indications for transfusion, as well as, improving the mechanical ventilatory support may decrease mortality and frequency of bronchopulmonary dysplasia in this patient group.
Downloads
Article Details
Creative Commons
License Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0)
You are free to:
Share - copy and redistribute the material in any medium or format.
Adapt - remix, transform, and build upon the material The licensor cannot revoke these freedoms as long as you follow the license terms.
• Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
• NonCommercial — You may not use the material for commercial purposes.
• ShareAlike — If you remix, transform, or build upon the material, you must distribute your contributions under the same license as the original.
• No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
References
Bronchopulmonary dysplasia
Pediatr Rev., 33 (2012), pp. 255-263 http://dx.doi.org/10.1542/pir.33-6-255
Medline
2 A.G. Philip
Bronchopulmonary dysplasia: Then and now
Neonatology., 102 (2012), pp. 1-8 http://dx.doi.org/10.1159/000336030
Medline
3 A.H. Jobe
The new bronchopulmonary dysplasia
Curr Opin Pediatr., 23 (2011), pp. 167-172 http://dx.doi.org/10.1097/MOP.0b013e3283423e6b
Medline
4 A. Trembath,M.M. Laughon
Predictors of bronchopulmonary dysplasia
Clin Perinatol., 39 (2012), pp. 585-601 http://dx.doi.org/10.1016/j.clp.2012.06.014
Medline
5 R.A. Ehrenkranz,M.C. Walsh,B.R. Vohr,A.H. Jobe,L.L. Wright,A.A. Fanaroff
Validation of the National Institutes of Health consensus definition of bronchopulmonary dysplasia
Pediatrics., 116 (2005), pp. 1353-1360 http://dx.doi.org/10.1542/peds.2005-0249
Medline
6 D.K. Edwards,W.M. Dyer,W.H. Northway Jr.
Twelve years’ experience with bronchopulmonary dysplasia
Pediatrics, 59 (1977), pp. 839-846
Medline
7 R. Álvarez,N. Regnícoli,R. Villavicencio,H. Oxilia
Displasia broncopulmonar: presente, pasado y futuro
Rev Arg Radiol., 68 (2004), pp. 71-77
8 C.P. Speer
Pre and postnatal inflammatory mechanisms in chronic lung disease of preterm infants
Paed Resp Rev., 5 (2004), pp. 24-44
9 S. Kotecha
Management of infants with chronic lung disease of prematurity in various parts of the world
Early Hum Dev., 81 (2005), pp. 133-134 http://dx.doi.org/10.1016/j.earlhumdev.2004.12.002
Medline
10 T. Farstad,D. Bratlid,S. Medbo,T. Markestad
Bronchopulmonary dysplasia prevalence, severity and predictive factors in a national cohort of extremely premature infants
Acta Paediatr., 100 (2011), pp. 53-58 http://dx.doi.org/10.1111/j.1651-2227.2010.01959.x
Medline
11 N. Ambalavanan,K.P. van Meurs,R. Perritt,W.A. Carlo,R.A. Ehrenkranz,D.K. Stevenson
Predictors of death or bronchopulmonary dysplasia in preterm infants with respiratory failure
J Perinatol., 28 (2008), pp. 420-426 http://dx.doi.org/10.1038/jp.2008.18
Medline
12 T.P. Stevens,E.W. Harrington,M. Blennow,R.F. Soll
Early surfactant administration with brief ventilation Vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome
Cochrane Database Syst Rev., 17 (2007), pp. CD003063
13 P. Korhonen,O. Tammela,A.-M. Koivisto,P. Laippala,S. Ikonen
Frequency and risk factor in bronchopulmonary dysplasia in a cohort of very low birth weight infants
Early Human Dev., 54 (1999), pp. 245-258
14 M.M. Laughon,J.C. Langer,C.L. Bose,P.B. Smith,N. Ambalavanan,K.A. Kennedy
Prediction of bronchopulmonary dysplasia by postnatal age in extremely premature infants
Am J Respir Crit Care Med., 183 (2011), pp. 1715-1722 http://dx.doi.org/10.1164/rccm.201101-0055OC
Medline
15 O.D. Saugstad
Bronchopulmonary dysplasia–oxidative stress and antioxidants
Semin Neonatol., 8 (2003), pp. 39-49
Medline
16 L.M. Askie,D.J. Henderson-Smart,H. Ko
Restricted versus liberal oxygen exposure for preventing morbidity and mortality in preterm or low birth weight infants
Cochrane Database of Syst Rev., (2009), pp. CD001077
17 X. Durrmeyer,G. Kayem,M. Sinico,G. Dassieu,C. Danan,F. Decobert
Perinatal risk factors for bronchopulmonary dysplasia in extremely low gestational age infants: A pregnancy disorder-based approach
J Pediatr., 160 (2012), pp. 578-583 http://dx.doi.org/10.1016/j.jpeds.2011.09.025
Medline
18 M. Vento,M. Aguar,J. Escobar,A. Arduini,R. Escrig,M. Brugada
Antenatal steroids and antioxidant enzyme activity in preterm infants: Influence of gender and timing
Antioxid Redox Signal., 11 (2009), pp. 2945-2955 http://dx.doi.org/10.1089/ars.2009.2671
Medline